News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,162 Results
Type
Article (2438)
Company Profile (39)
Press Release (35685)
Section
Business (14136)
Career Advice (77)
Deals (2081)
Drug Delivery (8)
Drug Development (4109)
Employer Resources (10)
FDA (431)
Job Trends (762)
News (20164)
Policy (1055)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (144)
Allergies (4)
Alliances (3485)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (433)
Artificial intelligence (9)
Autoimmune disease (2)
Automation (1)
Bankruptcy (11)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (17)
Cancer (132)
Cardiovascular disease (4)
Career advice (64)
Career pathing (1)
CAR-T (14)
Cell therapy (42)
Cervical cancer (2)
Clinical research (3179)
Collaboration (89)
Compensation (44)
COVID-19 (180)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (105)
Denatured (3)
Depression (3)
Diabetes (9)
Diagnostics (464)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4234)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6005)
Executive appointments (89)
FDA (476)
Featured Employer (3)
Funding (74)
Gene editing (14)
Gene therapy (17)
GLP-1 (60)
Government (150)
Healthcare (707)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (15)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (989)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (3)
Layoffs (36)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (18)
MASH (4)
Medical device (310)
Medtech (310)
Mergers & acquisitions (1154)
Metabolic disorders (32)
Multiple sclerosis (6)
Neurodegenerative disease (8)
Neuropsychiatric disorders (3)
Neuroscience (88)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (334)
Now hiring (4)
Obesity (15)
Opinion (15)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (19)
Patient recruitment (4)
Peanut (1)
People (5636)
Pharmaceutical (5)
Phase I (1374)
Phase II (1594)
Phase III (848)
Pipeline (71)
Podcasts (4)
Policy (12)
Postmarket research (30)
Preclinical (588)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (22)
Real estate (419)
Recruiting (5)
Regulatory (806)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (24)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (338)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (488)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1640)
Vaccines (28)
Venture capitalists (7)
Webinars (2)
Weight loss (11)
Women's health (1)
Worklife (1)
Date
Today (10)
Last 7 days (63)
Last 30 days (227)
Last 365 days (2571)
2025 (641)
2024 (2618)
2023 (2861)
2022 (3755)
2021 (4052)
2020 (3474)
2019 (2066)
2018 (1554)
2017 (1800)
2016 (1626)
2015 (1840)
2014 (1374)
2013 (1192)
2012 (1399)
2011 (1335)
2010 (1185)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1878)
Australia (301)
California (775)
Canada (130)
China (38)
Colorado (19)
Connecticut (10)
Delaware (3)
Europe (3816)
Florida (43)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (31)
Japan (9)
Kansas (12)
Maryland (25)
Massachusetts (286)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (2)
New Hampshire (2)
New Jersey (66)
New York (45)
North Carolina (88)
Northern California (334)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (46)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (338)
Tennessee (2)
Texas (67)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (47)
Wisconsin (6)
38,162 Results for "senda biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Senda Biosciences Appoints Igor Matushansky as Chief Medical Officer
Senda Biosciences, Inc. today announced the appointment of Igor Matushansky, M.D., Ph.D., as Chief Medical Officer.
July 24, 2023
·
5 min read
Business
Senda Biosciences Appoints Marc Wolfgang as Senior Vice President, Manufacturing
Senda Biosciences, Inc., a Flagship Pioneering company pioneering programmable medicines, announced the appointment of Marc Wolfgang as Senior Vice President, Manufacturing.
June 12, 2023
·
3 min read
Deals
Flagship’s Laronde, Senda Form Company Focused on New Class of Medicines
Sail Biomedicines combines Laronde’s circular eRNA platform with Senda’s nanoparticle delivery technology in the pursuit of a new class of programmable medicines across therapeutic areas.
October 20, 2023
·
2 min read
·
Tristan Manalac
Business
Senda Biosciences Appoints Luke O’Neill, Ph.D., as Chief Scientific Officer
Senda Biosciences, Inc., a company harnessing nature to enable the world’s first comprehensive programming of medicines, today announced the appointment of Luke O’Neill, Ph.D., as Chief Scientific Officer.
January 12, 2023
·
3 min read
Business
Senda Biosciences Bolsters Executive Leadership Team
Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the appointments of Lori Rudolph-Owen, Ph.D., as Chief Operating Officer, and Barbara Bispham, J.D., as SVP, General Counsel.
October 19, 2022
·
4 min read
Business
Senda Biosciences Appoints MIT Institute Professor Paula Hammond, Ph.D., to Its Board of Directors
Senda Biosciences, Inc. announced the appointment of Paula Hammond, Ph.D., Institute Professor and Head of MIT’s Department of Chemical Engineering, to the Company’s Board of Directors.
December 14, 2022
·
4 min read
Genetown
Senda Biosciences Announces Close of $123 Million Series C Financing
Senda Biosciences , Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the completion of a $123 million Series C financing, bringing its total funding raised to date to $266 million.
August 16, 2022
·
4 min read
Business
Senda Biosciences Scores $226M to Advance Programmable Medicines Platform
Proceeds from the fund activities will be used to back Senda’s proprietary programmable medicines platform and advance its projects to clinical trial stages.
August 16, 2022
·
2 min read
·
Vanessa Doctor, RN
Business
Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology
Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent and tunable medicines, has appointed Stuart Milstein, Ph.D., to the newly created position of Senior Vice President and Head of Platform Biology.
January 26, 2022
·
5 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
1 of 3,817
Next
